ZNF564
Zinc finger protein 564
Also known as: MGC26914, ZN564_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TBZ8
- Gene
- ZNF564
- Ensembl
- ENSG00000249709
- Chromosome
- 19
- Canonical length
- 553 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
553 residues, UniProt reviewed canonical sequence.
>Q8TBZ8|ZNF564
1 MDSVASEDVA VNFTLEEWAL LDPSQKKLYR DVMRETFRNL ACVGKKWEDQ SIEDWYKNQG
61 RILRNHMEEG LSESKEYDQC GEAFSQILNL NLNKKIPTIV RPCECSLCGK VFMHHSSLSR
121 HIRSHLGHKP YDYQEYGEKP YKCKQCGKAF SSCQSFRRHE RTHTGEKPYA CPECGKAFIS
181 LPSVRRHMIK HTGDGPYKCQ ECGKAFDRPS LFQIHERTHT GEKPYECQEC AKAFISLPSF
241 QRHMIRHTGD GPYKCQECGK AFDRPSLFRI HERTHTGEKP HECKQCGKAF ISFTNFQSHM
301 IRHTGDGPYK CKVCGRAFIF PSYVRKHERT HTGEKPYECN KCGKTFSSSS NVRTHERTHT
361 GEKPYECKEC GKAFISLPSV RRHMIKHTGD GPYKCQVCGR AFDCPSSFQI HERTHTGEKP
421 YECQVCGKAF ISLKRIRKHM ILHTGDGPYK CQVCGKAFDC PSSVRTHERT HTGEKPYECK
481 ECGKAFNYAS SIRIHERTHT GEKPYECKQC GKTFSYSSSF QRHERAHNGD KPYVKNVGKL
541 SFITQPSNTC ENELocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF564 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 7.5 nTPM
Expression across tissuesHPA
Tissue
- tongue: 7.5 nTPM
- thyroid gland: 7.4 nTPM
- kidney: 7.2 nTPM
- parathyroid gland: 7.1 nTPM
- breast: 7 nTPM
- thymus: 7 nTPM
Single-cell type
- myosatellite cells: 2.3 nCPM
- conjunctival goblet cells: 1 nCPM
- respiratory deuterosomal cells: 1 nCPM
- salivary duct cells: 1 nCPM
- corticotrophs: 0.9 nCPM
- granulosa cells: 0.8 nCPM
Immune cell
- eosinophil: 19 nTPM
- basophil: 15 nTPM
- memory B-cell: 15 nTPM
- neutrophil: 14 nTPM
- non-classical monocyte: 13 nTPM
- gdT-cell: 12 nTPM
Brain region
- cerebellum: 38 nTPM
- white matter: 31 nTPM
- cerebral cortex: 26 nTPM
- medulla oblongata: 25 nTPM
- pons: 25 nTPM
- basal ganglia: 24 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.03
- gnomAD pLI
- 0.36
- gnomAD missense Z
- 1.08
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZNF564 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF564 as an antibody target. Whether an autoantibody or antibody against ZNF564 could matter depends on whether native ZNF564 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF564 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF564 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...